Using Extracellular Vesicles Derived from Human Umbilical Cord Mesenchymal Stem Cells for a Topical Coating Promotes Oral Mucositis Healing in Rats

Overview

Journal Ann Transl Med

Publisher AME Publishing Company

Date 2022 Apr 18

PMID 35434027

Authors

Zhe Gao

Lixun Guan

Zhanxiang Liu

Fei Yan

Shu Fang

Xiangmei Zhang

Chunji Gao

Affiliations

Soon will be listed here.

Abstract

Background: Oral mucositis (OM) affects the quality of life and therapeutic outcomes of cancer patients. More effective drugs and methods for treating OM are urgently required for clinical application. Extracellular vesicles can play important roles in cutaneous wound healing. However, their role in OM remains unclear. Our aim was to investigate the function and mechanisms of topical coatings of extracellular vesicles derived from human umbilical cord mesenchymal stem cells (hUC-MSC-EVs) in OM.

Methods: HUC-MSC-EVs were isolated by differential ultracentrifugation. We used glacial acetic acid to induce the formation of OM in rats. HUC-MSC-EVs were covered on the OM topically once a day. Rats' body weights were measured on alternative days. The healing degree of OM was evaluated with macroscopic observations and histological examinations. We also analyzed the mechanisms of hUC-MSC-EVs when promoting the healing of OM. The expression levels of NF-κB, IL-6, TNF-α, and IL-1β in mucosal tissue were evaluated using immunohistochemistry.

Results: The median healing time of OM in the blank control, rhaFGF, 0.25 µg/µL EVs, 0.75 µg/µL EVs, and 1.50 µg/µL EVs groups was 14, 11, 10, 7, and 11 days, respectively. The most significant effect of hUC-MSC-EVs in promoting healing was at the concentration of 0.75 µg/µL. The median healing scores in the 0.75 µg/µL EVs group were 4 on day 5 and 3 on day 8 (*P<0.05 the blank control group). After modeling, the body weight of rats started to recover from day 8 in the blank control group and day 4 in the 0.75 µg/µL EVs group. The 0.75 µg/µL EVs group showed lower immunostaining intensity of NF-κB, IL-6, and TNF-α on day 5 and 8 (*P<0.05 the blank control group). However, there was no significant difference between the blank control group and the 0.75 µg/µL EVs group in IL-1β.

Conclusions: Our results showed for the first time that coating hUC-MSC-EVs topically can promote healing of OM because it may inhibit the activation of the NF-κB signaling pathway.

Citing Articles

[Research advances on the mechanism of oral mucosal stem cells in promoting wound healing].

Wei Z, Dong Y, Li G, Liu L Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2023; 39(5):496-500.

PMID: 37805762 PMC: 11630331. DOI: 10.3760/cma.j.cn501225-20220730-00321.

Extracellular Vesicles Derived from Mesenchymal Stem Cells Promote Wound Healing and Skin Regeneration by Modulating Multiple Cellular Changes: A Brief Review.

Zhang W, Ling Y, Sun Y, Xiao F, Wang L Genes (Basel). 2023; 14(8).

PMID: 37628568 PMC: 10453884. DOI: 10.3390/genes14081516.

References

Sonis S . The pathobiology of mucositis. Nat Rev Cancer. 2004; 4(4):277-84. DOI: 10.1038/nrc1318. View

Pulito C, Cristaudo A, La Porta C, Zapperi S, Blandino G, Morrone A . Oral mucositis: the hidden side of cancer therapy. J Exp Clin Cancer Res. 2020; 39(1):210. PMC: 7542970. DOI: 10.1186/s13046-020-01715-7. View

Lalla R, Bowen J, Barasch A, Elting L, Epstein J, Keefe D . MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2014; 120(10):1453-61. PMC: 4164022. DOI: 10.1002/cncr.28592. View

Chen C, Zhang Q, Yu W, Chang B, Le A . Oral Mucositis: An Update on Innate Immunity and New Interventional Targets. J Dent Res. 2020; 99(10):1122-1130. PMC: 7443999. DOI: 10.1177/0022034520925421. View

Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D . Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8(4):315-7. DOI: 10.1080/14653240600855905. View

Rubenstein E, Peterson D, Schubert M, Keefe D, McGuire D, Epstein J . Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer. 2004; 100(9 Suppl):2026-46. DOI: 10.1002/cncr.20163. View

Sonis S, Oster G, Fuchs H, Bellm L, BRADFORD W, Edelsberg J . Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol. 2001; 19(8):2201-5. DOI: 10.1200/JCO.2001.19.8.2201. View

Rani S, Ritter T . The Exosome - A Naturally Secreted Nanoparticle and its Application to Wound Healing. Adv Mater. 2015; 28(27):5542-52. DOI: 10.1002/adma.201504009. View

He X, Dong Z, Cao Y, Wang H, Liu S, Liao L . MSC-Derived Exosome Promotes M2 Polarization and Enhances Cutaneous Wound Healing. Stem Cells Int. 2019; 2019:7132708. PMC: 6754952. DOI: 10.1155/2019/7132708. View

10.

Ribeiro S, Araujo A, Oliveira M, Santos Silva A, da Silva-Junior A, Guerra G . Effect of Dexamethasone-Loaded PLGA Nanoparticles on Oral Mucositis Induced by 5-Fluorouracil. Pharmaceutics. 2021; 13(1). PMC: 7823510. DOI: 10.3390/pharmaceutics13010053. View

11.

Yang L, Pan J . Therapeutic Effect of Ecdysterone Combine Paeonol Oral Cavity Direct Administered on Radiation-Induced Oral Mucositis in Rats. Int J Mol Sci. 2019; 20(15). PMC: 6695810. DOI: 10.3390/ijms20153800. View

12.

Sonis S . Pathobiology of oral mucositis: novel insights and opportunities. J Support Oncol. 2007; 5(9 Suppl 4):3-11. View

13.

Barnes P, Karin M . Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997; 336(15):1066-71. DOI: 10.1056/NEJM199704103361506. View

14.

Ti D, Hao H, Tong C, Liu J, Dong L, Zheng J . LPS-preconditioned mesenchymal stromal cells modify macrophage polarization for resolution of chronic inflammation via exosome-shuttled let-7b. J Transl Med. 2015; 13:308. PMC: 4575470. DOI: 10.1186/s12967-015-0642-6. View

15.

Chaudhry H, Bruce A, Wolf R, Litzow M, Hogan W, Patnaik M . The Incidence and Severity of Oral Mucositis among Allogeneic Hematopoietic Stem Cell Transplantation Patients: A Systematic Review. Biol Blood Marrow Transplant. 2015; 22(4):605-616. DOI: 10.1016/j.bbmt.2015.09.014. View

16.

Thery C, Amigorena S, Raposo G, Clayton A . Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol. 2008; Chapter 3:Unit 3.22. DOI: 10.1002/0471143030.cb0322s30. View

17.

Jarrige M, Frank E, Herardot E, Martineau S, Darle A, Benabides M . The Future of Regenerative Medicine: Cell Therapy Using Pluripotent Stem Cells and Acellular Therapies Based on Extracellular Vesicles. Cells. 2021; 10(2). PMC: 7912181. DOI: 10.3390/cells10020240. View

18.

Wang X, Jiao Y, Pan Y, Zhang L, Gong H, Qi Y . Fetal Dermal Mesenchymal Stem Cell-Derived Exosomes Accelerate Cutaneous Wound Healing by Activating Notch Signaling. Stem Cells Int. 2019; 2019:2402916. PMC: 6590601. DOI: 10.1155/2019/2402916. View

19.

Basile D, Di Nardo P, Corvaja C, Garattini S, Pelizzari G, Lisanti C . Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside. Cancers (Basel). 2019; 11(6). PMC: 6627284. DOI: 10.3390/cancers11060857. View

20.

Hu L, Wang J, Zhou X, Xiong Z, Zhao J, Yu R . Exosomes derived from human adipose mensenchymal stem cells accelerates cutaneous wound healing via optimizing the characteristics of fibroblasts. Sci Rep. 2016; 6:32993. PMC: 5018733. DOI: 10.1038/srep32993. View